适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- CHU Nantes
- 入组人数
- 385
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 385
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
1 期
First in human clinical trial to evaluate the safety, tolerability and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancerProgressive metastatic solid cancer after failure of established treatment optionsMedDRA version: 20.0Level: LLTClassification code: 10031295Term: Osteosarcoma NOS Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10006188Term: Breast cancer female NOS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10024631Term: Liposarcoma NOS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10042866Term: Synovial sarcoma NOS Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10010029Term: Colorectal cancer NOS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10024193Term: Leiomyosarcoma NOS Class: 10029104CTIS2022-503084-15-00Deutsches Krebsforschungszentrum (DKFZ)77
进行中（未招募）
1 期
A randomized, Phase 1b, single-center, observer-blind, active-controlled study to evaluate the safety, immunogenicity, and immunological mechanisms of one single administration of TETRALITE influenza vaccine at two dose levels of LiteVax Adjuvant, in healthy participants aged 60 years and older and in healthy participants aged 18 to 50 years.InfluenzaCTIS2023-508230-33-00iteVax B.V.70
进行中（未招募）
3 期
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Japanese Adults With HypoparathyroidismHypoparathyroidismJPRN-jRCT2051210058Sibley Christopher12
进行中（未招募）
不适用
/ACerebral venous thrombosisEUCTR2010-020302-15-PTIMM - Instituto de Medicina Molecular164
进行中（未招募）
不适用
/AEUCTR2011-002271-42-DEniversity Medical Center Goettingen